Friday, June 20, 2014

FDA grants orphan drug designation to Alexion's Soliris to treat Myasthenia Gravis | Nephrology News & Issues

FDA grants orphan drug designation to Alexion's Soliris to treat Myasthenia Gravis | Nephrology News & Issues



My father had MG.  He was given medication and his body reacted so severely he died from the drug reaction.  It was a sad day.  Hopefully this new medication will give relief and hope to those who suffer from MG.



Blessings

No comments:

Post a Comment